Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 317

1.

Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes.

Tezenas du Montcel S, Durr A, Bauer P, Figueroa KP, Ichikawa Y, Brussino A, Forlani S, Rakowicz M, Schöls L, Mariotti C, van de Warrenburg BP, Orsi L, Giunti P, Filla A, Szymanski S, Klockgether T, Berciano J, Pandolfo M, Boesch S, Melegh B, Timmann D, Mandich P, Camuzat A; Clinical Research Consortium for Spinocerebellar Ataxia (CRC-SCA); the EUROSCA network, Goto J, Ashizawa T, Cazeneuve C, Tsuji S, Pulst SM, Brusco A, Riess O, Brice A, Stevanin G.

Brain. 2014 Jun 26. pii: awu174. [Epub ahead of print]

PMID:
24972706
[PubMed - as supplied by publisher]
2.

Spinocerebellar ataxia type 10 in Peru: the missing link in the Amerindian origin of the disease.

Leonardi L, Marcotulli C, McFarland KN, Tessa A, DiFabio R, Santorelli FM, Pierelli F, Ashizawa T, Casali C.

J Neurol. 2014 Jun 17. [Epub ahead of print]

PMID:
24935856
[PubMed - as supplied by publisher]
3.

Quantitative trait locus analysis of resistance to panicle blast in the rice cultivar Miyazakimochi.

Ishihara T, Hayano-Saito Y, Oide S, Ebana K, La NT, Hayashi K, Ashizawa T, Suzuki F, Koizumi S.

Rice (N Y). 2014 Apr 10;7(1):2. doi: 10.1186/s12284-014-0002-9. eCollection 2014.

PMID:
24920970
[PubMed]
Free PMC Article
4.

YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line.

Akiyama Y, Ashizawa T, Komiyama M, Miyata H, Oshita C, Omiya M, Iizuka A, Kume A, Sugino T, Hayashi N, Mitsuya K, Nakasu Y, Yamaguchi K.

Oncol Rep. 2014 Jul;32(1):159-66. doi: 10.3892/or.2014.3195. Epub 2014 May 16.

PMID:
24842123
[PubMed - in process]
5.

Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line.

Ashizawa T, Akiyama Y, Miyata H, Iizuka A, Komiyama M, Kume A, Omiya M, Sugino T, Asai A, Hayashi N, Mitsuya K, Nakasu Y, Yamaguchi K.

Int J Oncol. 2014 Jul;45(1):411-8. doi: 10.3892/ijo.2014.2439. Epub 2014 May 12.

PMID:
24820265
[PubMed - in process]
6.

The identification of affinity peptide ligands specific to the variable region of human antibodies.

Akiyama Y, Miyata H, Komiyama M, Nogami M, Ozawa K, Oshita C, Kume A, Ashizawa T, Sakura N, Mochizuki T, Yamaguchi K.

Biomed Res. 2014;35(2):105-16.

PMID:
24759178
[PubMed - in process]
Free Article
7.

Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients.

Akiyama Y, Komiyama M, Miyata H, Yagoto M, Ashizawa T, Iizuka A, Oshita C, Kume A, Nogami M, Ito I, Watanabe R, Sugino T, Mitsuya K, Hayashi N, Nakasu Y, Yamaguchi K.

Oncol Rep. 2014 Apr;31(4):1683-90. doi: 10.3892/or.2014.3049. Epub 2014 Feb 24.

PMID:
24573400
[PubMed - in process]
8.

Anti-vascular endothelial growth factor receptor (VEGFR) 2 autoantibody identification in glioblastoma patient using single B cell-based antibody gene cloning.

Iizuka A, Komiyama M, Oshita C, Kume A, Ashizawa T, Mitsuya K, Hayashi N, Nakasu Y, Yamaguchi K, Akiyama Y.

Immunol Lett. 2014 May-Jun;159(1-2):15-22. doi: 10.1016/j.imlet.2014.02.004. Epub 2014 Feb 15.

PMID:
24534640
[PubMed - in process]
9.

Group A Streptococcus pharyngitis outbreak among university students in a judo club.

Aoki A, Ashizawa T, Ebata A, Nasu Y, Fujii T.

J Infect Chemother. 2014 Mar;20(3):190-3. doi: 10.1016/j.jiac.2013.10.004. Epub 2013 Dec 11.

PMID:
24462434
[PubMed - in process]
10.

Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies.

Bachinski LL, Baggerly KA, Neubauer VL, Nixon TJ, Raheem O, Sirito M, Unruh AK, Zhang J, Nagarajan L, Timchenko LT, Bassez G, Eymard B, Gamez J, Ashizawa T, Mendell JR, Udd B, Krahe R.

Neuromuscul Disord. 2014 Mar;24(3):227-40. doi: 10.1016/j.nmd.2013.11.001. Epub 2013 Nov 15.

PMID:
24332166
[PubMed - in process]
11.

Repeat interruptions in spinocerebellar ataxia type 10 expansions are strongly associated with epileptic seizures.

McFarland KN, Liu J, Landrian I, Zeng D, Raskin S, Moscovich M, Gatto EM, Ochoa A, Teive HA, Rasmussen A, Ashizawa T.

Neurogenetics. 2014 Mar;15(1):59-64. doi: 10.1007/s10048-013-0385-6. Epub 2013 Dec 7.

PMID:
24318420
[PubMed - in process]
12.

Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias.

Matilla-Dueñas A, Ashizawa T, Brice A, Magri S, McFarland KN, Pandolfo M, Pulst SM, Riess O, Rubinsztein DC, Schmidt J, Schmidt T, Scoles DR, Stevanin G, Taroni F, Underwood BR, Sánchez I.

Cerebellum. 2014 Apr;13(2):269-302. doi: 10.1007/s12311-013-0539-y.

PMID:
24307138
[PubMed - in process]
13.

[Risk and sex factor on suicide among substance use disorder patients].

Matsumoto T, Matsushita S, Okudaira K, Naruse N, Cho T, Muto T, Ashizawa T, Konuma K, Morita N, Ino A.

Seishin Shinkeigaku Zasshi. 2013;115(7):703-10. Japanese. No abstract available.

PMID:
24288821
[PubMed - indexed for MEDLINE]
14.

Expansion of the Spinocerebellar ataxia type 10 (SCA10) repeat in a patient with Sioux Native American ancestry.

Bushara K, Bower M, Liu J, McFarland KN, Landrian I, Hutter D, Teive HA, Rasmussen A, Mulligan CJ, Ashizawa T.

PLoS One. 2013 Nov 20;8(11):e81342. doi: 10.1371/journal.pone.0081342. eCollection 2013.

PMID:
24278426
[PubMed - in process]
Free PMC Article
15.

Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study.

Ashizawa T, Figueroa KP, Perlman SL, Gomez CM, Wilmot GR, Schmahmann JD, Ying SH, Zesiewicz TA, Paulson HL, Shakkottai VG, Bushara KO, Kuo SH, Geschwind MD, Xia G, Mazzoni P, Krischer JP, Cuthbertson D, Holbert AR, Ferguson JH, Pulst SM, Subramony SH.

Orphanet J Rare Dis. 2013 Nov 13;8:177. doi: 10.1186/1750-1172-8-177.

PMID:
24225362
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Mutation in the kv3.3 voltage-gated potassium channel causing spinocerebellar ataxia 13 disrupts sound-localization mechanisms.

Middlebrooks JC, Nick HS, Subramony SH, Advincula J, Rosales RL, Lee LV, Ashizawa T, Waters MF.

PLoS One. 2013 Oct 7;8(10):e76749. doi: 10.1371/journal.pone.0076749. eCollection 2013.

PMID:
24116147
[PubMed - in process]
Free PMC Article
17.

Spinocerebellar ataxia type 10: from Amerindians to Latin Americans.

Teive HA, Ashizawa T.

Curr Neurol Neurosci Rep. 2013 Nov;13(11):393. doi: 10.1007/s11910-013-0393-9. No abstract available.

PMID:
24027006
[PubMed - indexed for MEDLINE]
18.

Comprehensive phenotype of the p.Arg420his allelic form of spinocerebellar ataxia type 13.

Subramony SH, Advincula J, Perlman S, Rosales RL, Lee LV, Ashizawa T, Waters MF.

Cerebellum. 2013 Dec;12(6):932-6. doi: 10.1007/s12311-013-0507-6.

PMID:
23912307
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Purkinje cell loss is the major brain pathology of spinocerebellar ataxia type 10.

Xia G, McFarland KN, Wang K, Sarkar PS, Yachnis AT, Ashizawa T.

J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1409-11. doi: 10.1136/jnnp-2013-305080. Epub 2013 Jun 29. No abstract available.

PMID:
23813740
[PubMed - indexed for MEDLINE]
20.

Diagnostic odyssey of patients with myotonic dystrophy.

Hilbert JE, Ashizawa T, Day JW, Luebbe EA, Martens WB, McDermott MP, Tawil R, Thornton CA, Moxley RT 3rd.

J Neurol. 2013 Oct;260(10):2497-504. doi: 10.1007/s00415-013-6993-0. Epub 2013 Jun 27.

PMID:
23807151
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk